INS and type 2 diabetes mellitus: The fact that these EV proteins and phosphoproteins were identified as central hubs in their respective pathway enrichment networks and that their changes significantly correlated with changes in relevant clinical variables, including measures of body composition, glycemic control, insulin action, and beta cell function, suggests that their presence and changes in abundance in the circulating EVs is important in the development of T2DM.